DC
Divya Chandu Patel
About Divya Chandu Patel
Data last updated:
Divya Chandu Patel is a Nominee Director at Alvogen Pharma (India) Private Limited (since 2010) and Director at Norwich Clinical Services Private Limited (since 2013). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹103 Cr; the largest is Alvogen Pharma (India) Private Limited at ₹51.32 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alvogen Pharma (India) Private Limited U74900KA2010PTC053204 | Nominee Director | 01 May 2010 | 2010 | ₹51.32 Cr (FY 2025) | Active |
| Norwich Clinical Services Private Limited U73100KA2009PTC051396 | Director | 28 Oct 2013 | 2009 | ₹51.26 Cr (FY 2025) | Active |
Board colleagues of Divya Chandu Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aditya Nagaraj Bellur | 07231827 | Alvogen Pharma (India) Private Limited , Norwich Clinical Services Private Limited | Director |
| Fjalar Kristjansson | 02504768 | Alvogen Pharma (India) Private Limited , Norwich Clinical Services Private Limited | Director |
| Saral Thangam | 01507119 | Alvogen Pharma (India) Private Limited , Norwich Clinical Services Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Divya Chandu Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Divya Chandu Patel
Divya Chandu Patel currently holds 2 directorships: Alvogen Pharma (India) Private Limited (Nominee Director, since 01 May 2010, revenue ₹51.32 Cr (FY 2025)); Norwich Clinical Services Private Limited (Director, since 28 Oct 2013, revenue ₹51.26 Cr (FY 2025)).
Divya Chandu Patel was first appointed on 01 May 2010 as Nominee Director at Alvogen Pharma (India) Private Limited. The most recent appointment on record is 28 Oct 2013 at Norwich Clinical Services Private Limited.
The 2 current companies of Divya Chandu Patel that report revenue have a combined latest revenue of ₹103 Cr: Alvogen Pharma (India) Private Limited ₹51.32 Cr (FY 2025); Norwich Clinical Services Private Limited ₹51.26 Cr (FY 2025).
The current boards of Divya Chandu Patel's companies include Aditya Nagaraj Bellur (Alvogen Pharma (India) Private Limited), Fjalar Kristjansson (Alvogen Pharma (India) Private Limited), Saral Thangam (Alvogen Pharma (India) Private Limited).